Should hearing targeted screening for congenital cytomegalovirus infection Be implemented?. (July 2020)

• Record Type: Journal Article
• Authors: Haller, Travis; Shoup, Angela; Park, Albert H.
• Is Part Of: International journal of pediatric otorhinolaryngology. Volume 134(2020:Jul.)
• Publication Date: 2020-07
• Subjects: Cytomegalovirus -- Sensorineural hearing loss -- Universal newborn hearing screening; Otolaryngology -- Periodicals; Pediatrics -- Periodicals; Otolaryngology -- Periodicals; Pediatrics -- Periodicals; Oto-rhino-laryngologie -- Périodiques; Pédiatrie -- Périodiques; 618.9209751
• DOI: 10.1016/j.ijporl.2020.110055
• Languages: English
• ISSNs: 0165-5876

Abstract

Abstract: Since 2013, after Utah became the first state to implement hearing targeted early CMV screening, a national debate has been percolating about whether this approach should be introduced nationally. Currently Utah, Iowa, Connecticut, and New York have passed legislation mandating early CMV screening, and over 100 birth hospitals across the United States have voluntarily implemented early CMV screening programs as part of their standard of care. We reviewed the evidence related to this approach and used the Wilson and Jungner (1968) criteria to evaluate this method of screening. Based on these criteria, there is substantial rationale and evidence to support a hearing targeted approach to screen for congenital CMV. Given this evidence, we currently recommend that infants who fail newborn hearing screen should undergo CMV screening.